Immune Response Against Lymphoma
Showing 1 - 25 of >10,000
Glutathione-cyclodextrin Complex Absorption Trial in Pomona (Glutaryl Solution, Placebo Solution)
Completed
- Glutathione-cyclodextrin Complex Absorption
- Glutaryl Solution
- Placebo Solution
-
Pomona, CaliforniaWestern University of Health Sciences
Jun 26, 2023
Cancer Trial in Anderlecht (Spikevax, Comirnaty)
Recruiting
- Cancer
- Spikevax
- Comirnaty
-
Anderlecht, Belgium
- +1 more
Aug 30, 2022
Normal Subjects and Disorders of Immune System and Cancer
Recruiting
- T-cell Lymphoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 24, 2023
Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)
Not yet recruiting
- Herpes Simplex
- HSVTI Formulation 1
- +2 more
-
Tokyo, JapanGSK Investigational Site
Aug 4, 2023
Influenza, Human Trial (Flu mRNA, Control 1, Control 2)
Not yet recruiting
- Influenza, Human
- Flu mRNA
- +2 more
- (no location specified)
Apr 21, 2023
Immune Response in Dialysis Patients Vaccinated Against COVID-19
Completed
- Covid19
- Chronic Kidney Disease 5D
-
Saint Petersburg, Russian FederationSaint-Petersburg State University Hospital
Feb 16, 2022
Meningitis, Meningococcal Trial in Korea, Republic of (rMenB+OMV NZ)
Not yet recruiting
- Meningitis, Meningococcal
- rMenB+OMV NZ
-
Anyang-Si, Gyeonggi-do, Korea, Republic of
- +6 more
Oct 27, 2023
Covid 19 Trial in France (patients COVID 19)
Recruiting
- Covid 19
- patients COVID 19
-
Antibes, Alpes Maritimes, France
- +3 more
Feb 18, 2022
Pertussis Immunisation, Diphtheria Immunisation, Tetanus Immunisation Trial in Cape Town (Tetanus Toxoid, Reduced Diphtheria
Recruiting
- Pertussis Immunisation
- +3 more
- Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine
-
Cape Town, South Africa
- +2 more
Dec 2, 2022
Comorbidities and Coexisting Conditions, Healthy Trial in Manaus (Vaccine - ChAdOx1-S/nCoV-19 [recombinant])
Active, not recruiting
- Comorbidities and Coexisting Conditions
- Healthy
- Vaccine - ChAdOx1-S/nCoV-19 [recombinant]
-
Manaus, Amazonas, BrazilFundação de Medicina Tropical Dr Heitor Vieira Dourado
May 3, 2022
After Vaccination Against COVID-19 in Patients Treated With
Recruiting
- Kidney Failure, Chronic
- +3 more
- Immune response
- Solicited common and expected adverse reactions shortly following vaccination (reactogenicity), use of antipyretic or pain medications and unsolicited adverse events and serious adverse events
-
Gdansk, Pomorskie, Poland
- +3 more
Feb 3, 2022
Respiratory Syncytial Virus Infections Trial in New Zealand, Panama, South Africa (RSVPreF3 OA investigational vaccine, FLU-QIV)
Completed
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- FLU-QIV
-
Auckland, New Zealand
- +13 more
Sep 20, 2022
Sepsis Syndrome Trial in New Orleans (MMR vaccine)
Recruiting
- Sepsis Syndrome
- MMR vaccine
-
New Orleans, LouisianaClinical and Translational Research Center
Apr 4, 2022
Salmonella Infections Trial (biological, combination product, drug, other)
Not yet recruiting
- Salmonella Infections
- Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose
- +10 more
- (no location specified)
Jul 27, 2022
Non-hodgkin Lymphoma,B Cell, Vaccination Failure Trial (Immunological analyses)
Not yet recruiting
- Non-hodgkin Lymphoma,B Cell
- Vaccination Failure
- Immunological analyses
- (no location specified)
Sep 13, 2021
Herpes Zoster Trial in India (HZ/su, Placebo)
Active, not recruiting
- Herpes Zoster
- HZ/su
- Placebo
-
Visakhapatnam, Andhra Pradesh, India
- +8 more
Jan 6, 2023
Virus Diseases Trial in Rochester (1 µg CoV2 SAM (LNP))
Completed
- Virus Diseases
- 1 µg CoV2 SAM (LNP)
-
Rochester, New YorkGSK Investigational Site
May 16, 2022
Vaccine-induced Immunity Against Ebola in Previously Vaccinated
Recruiting
- Immune Response
-
Goma, Congo, The Democratic Republic of the
- +1 more
May 18, 2022
COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)
Not yet recruiting
- COVID-19
- mRNA-CR-04 vaccine 10μg
- +3 more
-
San Diego, California
- +3 more
Aug 1, 2023
SARS-CoV-2 Vaccines in Chronic Lymphocytic Leukemia or Small
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Biospecimen Collection
- Electronic Health Record Review
-
Duarte, California
- +10 more
Jan 12, 2023
Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)
Recruiting
- Metastatic Malignant Solid Neoplasm
- Lymphoma
- Positron Emission Tomography
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Immune Response Against COVID-19 Among Hospital Staff
Active, not recruiting
- Sars-CoV2
- Clinical interview
- +2 more
-
Clamart, FranceHôpital d'Instuction des Armées Percy
Jul 6, 2021
Vaccination Reaction, COVID-19, Vaccination; Infection Trial in Cologne (Comirnaty(BTN162b2), Spikevax (mRNA-1273))
Recruiting
- Vaccination Reaction
- +2 more
- Comirnaty(BTN162b2)
- Spikevax (mRNA-1273)
-
Cologne, GermanyUniversity Hospital Cologne
Jan 27, 2022
Malaria, Dengue Trial in Mae Sot (Mosquito bites)
Recruiting
- Malaria
- Dengue
- Mosquito bites
-
Mae Sot, Tak, ThailandShoklo Malaria Research unit (SMRU)
Aug 13, 2021